Belonging to Laboratório Nacional de Computação Científica and SENAI CIMATEC, the significant-general performance pcs Santos Dumont and Ogbon, both made by Atos, are staying employed on scientific tests for the progress of medicines and vaccines in opposition to COVID-19
Brazil, 27 April 2020
Atos, a world-wide leader in digital transformation, announces that two of its supercomputers in Brazil are staying employed in research for the progress of vaccines and medication in opposition to the coronavirus. These are Santos Dumont, which belongs to the Nationwide Laboratory for Scientific Computing (LNCC), and Ogbon, at SENAI CIMATEC. The supercomputers are thought of the most significant in Brazil and in South America and are in the Leading 500 record of the most effective supercomputers in the environment. The initiative is led by the Chemistry Office at Stanford College, in the United States.
The intention is to contribute to the [email protected] task, coordinated by the College, which scientific tests the evolution of the coronavirus in the human overall body, primarily based on the interaction of viral proteins, which opens the way for the progress of unique vaccines and medications. Owing to their significant general performance and ability, the two supercomputers are preferably located to contribute to this kind of research. They can be employed for parallel processing, complex calculations and in depth and intensive responsibilities – processes that demand from customers quadrillions of calculations for each next.
Santos Dumont, mounted at LNCC, in Rio de Janeiro, aims to have 60% of its ability committed to the [email protected] task, which is two petaflops (equal to the computational ability of two million laptops operating jointly). Ogbon, located at the SENAI CIMATEC Supercomputing Middle, in Salvador, aims to have 50% of its ability devoted to research, which corresponds to one petaflops (or one million laptops).
“Our objective is to join individuals, know-how and firms to enable improve the environment in which we stay. The use of our supercomputers in the fight in opposition to Covid-19’s development is specifically this. We are quite very pleased to deliver significant-general performance know-how to assistance and establish research that can conserve hundreds of thousands of lives”, states Luis Casuscelli, Director of Major Info and Cybersecurity at Atos in South America. “Atos equipment have presently supported LNCC researchers to identify the supply of the virus’s entry, and to identify that each individual diverse supply has a diverse attribute –which will assistance researchers and researchers generate a lot more helpful vaccines.”
Atos is a world-wide leader in digital transformation with above a hundred and ten,000 workers in seventy three international locations and once-a-year profits of above € eleven billion. European amount one particular in Cloud, Cybersecurity and Superior-Overall performance Computing, the Group provides end-to-end Orchestrated Hybrid Cloud, Major Info, Business enterprise Applications and Digital Office answers. The group is the All over the world Information Technological know-how Spouse for the Olympic & Paralympic Video games and operates less than the brands Atos, Atos Syntel, and Unify. Atos is a SE (Societas Europaea), outlined on the CAC40 Paris stock index.
The objective of Atos is to enable layout the long term of the details know-how house. Its knowledge and providers assistance the progress of understanding, schooling as well as multicultural and pluralistic techniques to research that contribute to scientific and technological excellence. Across the environment, the group permits its buyers, workers and collaborators, and associates of societies at big to stay, work and establish sustainably and confidently in the details know-how house.
Push get hold of:
Laura Fau | [email protected] | +33 6 seventy three sixty four 04 eighteen | @laurajanefau